.. Comparaison-des-résultats-avec-les-données-de-la-littérature, 49, (! %B! ):6;+*.2:8!S!43*+*-.!.,H0-<<-.!-2!<-03(! %N! 1. Stevens A, Johnson F. A new eruptive fever associated with stomatitis and ophtalmiaT: report of two cases in children, pp.867-869, 1922.

A. Lyell, TOXIC EPIDERMAL NECROLYSIS: AN ERUPTION RESEMBLING SCALDING OF THE SKIN., British Journal of Dermatology, vol.30, issue.11, pp.355-61, 1956.
DOI : 10.1111/j.1365-2133.1956.tb12766.x

S. Bastuji-garin, B. Rzany, R. Stern, N. Shear, L. Naldi et al., Clinical Classification of Cases of Toxic Epidermal Necrolysis, Stevens-Johnson Syndrome, and Erythema Multiforme, Archives of Dermatology, vol.129, issue.1, pp.92-98, 1993.
DOI : 10.1001/archderm.1993.01680220104023

J. Roujeau, J. Kelly, L. Naldi, B. Rzany, R. Stern et al., Medication Use and the Risk of Stevens???Johnson Syndrome or Toxic Epidermal Necrolysis, New England Journal of Medicine, vol.333, issue.24, pp.1600-1607, 1995.
DOI : 10.1056/NEJM199512143332404

J. Roujeau, O. Chosidow, P. Saiag, and J. Guillaume, Toxic epidermal necrolysis (Lyell syndrome), Journal of the American Academy of Dermatology, vol.23, issue.6, pp.1039-58, 1990.
DOI : 10.1016/0190-9622(90)70333-D

P. Paquet, Drugs involved in toxic epidermal necrolysis (Lyell's syndrome)

J. Roujeau, K. Gélard, and A. Bensussan, N??crolyse ??pidermique : M??canisme de l???apoptose des k??ratinocytes, m??decine/sciences, vol.22, issue.2, pp.188-91, 2006.
DOI : 10.1051/medsci/2006222188

. Stevens-johnson, syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study, J Invest Dermatol, vol.128, pp.35-44, 2008.

H. Assier, S. Bastuji-garin, J. Revuz, and J. Roujeau, Erythema Multiforme With Mucous Membrane Involvement and Stevens-Johnson Syndrome Are Clinically Different Disorders With Distinct Causes, Archives of Dermatology, vol.131, issue.5, pp.539-582, 1995.
DOI : 10.1001/archderm.1995.01690170041005

A. Auquier-dunant, M. Mockenhaupt, L. Naldi, O. Correia, W. Schröder et al., Correlations Between Clinical Patterns and Causes of Erythema Multiforme Majus, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.138, issue.8, pp.1019-1043, 2002.
DOI : 10.1001/archderm.138.8.1019

G. Achten and M. Ledoux-corbusier, Lyell's toxic epidermal necrolysis: histologic aspects], Arch Belg Dermatol Syphiligr, vol.26, pp.97-114, 1970.

A. Lyell, Drug-induced toxic epidermal necrolysis. I. An overview, Clinics in Dermatology, vol.11, issue.4, pp.491-493, 1993.
DOI : 10.1016/0738-081X(93)90155-6

L. French, Toxic Epidermal Necrolysis and Stevens Johnson Syndrome: Our Current Understanding, Allergology International, vol.55, issue.1, pp.9-16, 2006.
DOI : 10.2332/allergolint.55.9

URL : http://doi.org/10.2332/allergolint.55.9

J. Roujeau, Toxic epidermal necrolysis and Stevens-Johnson syndrome], Rev Prat, vol.57, pp.1165-70, 2007.
URL : https://hal.archives-ouvertes.fr/inserm-00624798

B. Rzany, O. Correia, J. Kelly, L. Naldi, A. Auquier et al., Risk of Stevens-Johnson syndrome and toxic epider mal necrolysis during first weeks of antiepileptic therapy: a case-control study, The Lancet, vol.353, issue.9171, pp.2190-2194, 1999.
DOI : 10.1016/S0140-6736(98)05418-X

H. Chan, Toxic Epidermal Necrolysis in Singapore, 1989 Through 1993: Incidence and Antecedent Drug Exposure, Archives of Dermatology, vol.131, issue.10, pp.1212-1215, 1989.
DOI : 10.1001/archderm.1995.01690220120030

P. Fritsch, R. Maldonado, and . Erythema-multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis New-York: Fitzpatrick's Dermatology in General Medicine, pp.543-57, 2003.

K. Duncan, R. Tigelaar, and J. Bolognia, Stevens-Johnson syndrome limited to multiple sites of radiation therapy in a patient receiving phenobarbital, Journal of the American Academy of Dermatology, vol.40, issue.3, pp.493-499, 1999.
DOI : 10.1016/S0190-9622(99)70508-6

D. Aguiar, R. Pazo, I. Durán, J. Terrasa, A. Arrivi et al., Toxic Epidermal Necrolysis in Patients Receiving Anticonvulsants and Cranial Irradiation: A Risk to Consider, Journal of Neuro-Oncology, vol.66, issue.3, pp.345-50, 2004.
DOI : 10.1023/B:NEON.0000014538.31561.bc

F. Aydin, C. Cokluk, N. Senturk, K. Aydin, M. Canturk et al., Stevens-Johnson syndrome in two patients treated with cranial irradiation and phenytoin, Journal of the European Academy of Dermatology and Venereology, vol.103, issue.5, pp.588-90, 2006.
DOI : 10.1159/000079094

J. Zakrzewski, G. Lentini, U. Such, A. Duerr, V. Tran et al., Toxic epidermal necrolysis: differential diagnosis of an epidermolytic dermopathy in a hematopoietic stem cell transplant recipient, Bone Marrow Transplantation, vol.30, issue.5, pp.331-334, 2002.
DOI : 10.1038/sj.bmt.1703624

W. Weston, Erythema multiforme and Stevens-Johnson syndrome. London: Mosby, pp.313-333, 2003.

L. French and C. Prins, Toxic epidermal necrolysis. London: Mosby, pp.323-354, 2003.

!. &%-!-27, R. Forman, G. Koren, and N. Shear, Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in children: a review of 10 years' experience, Drug Saf Int J Med Toxicol Drug Exp, vol.25, pp.965-72, 2002.

R. Mandelcorn and N. Shear, Lupus-associated toxic epidermal necrolysis: A novel manifestation of lupus?, Journal of the American Academy of Dermatology, vol.48, issue.4, pp.525-534, 2003.
DOI : 10.1067/mjd.2003.107

Y. Aihara, S. Ito, Y. Kobayashi, and M. Aihara, Stevens-Johnson syndrome associated with azithromycin followed by transient reactivation of herpes simplex virus infection, Allergy, vol.59, issue.1, p.118, 2004.
DOI : 10.1001/archderm.136.3.323

Y. Merot and J. Saurat, Clues to Pathogenesis of Toxic Epidermal Necrolysis, International Journal of Dermatology, vol.132, issue.3, pp.165-173, 1985.
DOI : 10.1001/archderm.98.5.528

H. Miyauchi, H. Hosokawa, T. Akaeda, H. Iba, and Y. Asada, T-Cell Subsets in Drug-Induced Toxic Epidermal Necrolysis, Archives of Dermatology, vol.127, issue.6
DOI : 10.1001/archderm.1991.01680050095011

G. Villada, J. Roujeau, T. Clérici, I. Bourgault, and J. Revuz, Immunopathology of toxic epidermal necrolysis. Keratinocytes, HLA-DR expression, Langerhans cells, and mononuclear cells: an immunopathologic study of five cases, Archives of Dermatology, vol.128, issue.1, pp.50-53, 1992.
DOI : 10.1001/archderm.128.1.50

O. Correia, L. Delgado, J. Ramos, C. Resende, and J. Torrinha, Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8+ lymphocyte involvement, Archives of Dermatology, vol.129, issue.4, pp.466-474, 1993.
DOI : 10.1001/archderm.129.4.466

C. Paul, P. Wolkenstein, H. Adle, J. Wechsler, H. Garchon et al., Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis, British Journal of Dermatology, vol.91, issue.4, pp.710-714, 1996.
DOI : 10.1016/0167-5699(94)90249-6

P. Paquet, A. Nikkels, J. Arrese, A. Vanderkelen, and G. Piérard, Macrophages and tumor necrosis factor alpha in toxic epidermal necrolysis, Archives of Dermatology, vol.130, issue.5, pp.605-613, 1994.
DOI : 10.1001/archderm.130.5.605

P. Paquet and G. Piérard, Soluble fractions of tumor necrosis factor-alpha, p.6

I. Viard, P. Wehrli, R. Bullani, P. Schneider, N. Holler et al., Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin, Science, vol.282, issue.5388, pp.490-493, 1998.
DOI : 10.1126/science.282.5388.490

N. Bachot, J. Revuz, and J. Roujeau, Intravenous Immunoglobulin Treatment for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.139, issue.1, pp.33-39, 2003.
DOI : 10.1001/archderm.139.1.33

!. &&-!-40, K. Brown, G. Silver, M. Halerz, P. Walaszek et al., Toxic epidermal necrolysis: does immunoglobulin make a difference?, J Burn Care Rehabil, vol.25, pp.81-89, 2004.

R. Shortt, M. Gomez, N. Mittman, and R. Cartotto, Intravenous Immunoglobulin Does Not Improve Outcome in Toxic Epidermal Necrolysis, Journal of Burn Care & Rehabilitation, vol.25, issue.3, pp.246-55, 2004.
DOI : 10.1097/01.BCR.0000124746.33279.86

R. Abe, T. Shimizu, A. Shibaki, H. Nakamura, H. Watanabe et al., Toxic Epidermal Necrolysis and Stevens-Johnson Syndrome Are Induced by Soluble Fas Ligand, The American Journal of Pathology, vol.162, issue.5, pp.1515-1535, 2003.
DOI : 10.1016/S0002-9440(10)64284-8

P. Paquet and G. Piérard, Keratinocyte injury in drug-induced toxic epidermal necrolysis: Simultaneous but distinct topographic expression of CD95R and calprotectin, International Journal of Molecular Medicine, vol.10, pp.145-152, 2002.
DOI : 10.3892/ijmm.10.2.145

W. Chung, S. Hung, H. Hong, M. Hsih, L. Yang et al., Medical genetics: A marker for Stevens???Johnson syndrome, Nature, vol.428, issue.6982, pp.486-534, 2004.
DOI : 10.1038/428486a

Y. Chang, F. Huang, S. Tseng, C. Hsu, C. Ho et al., Erythema Multiforme, Stevens-Johnson Syndrome, and Toxic Epidermal Necrolysis, Cornea, vol.26, issue.2, pp.123-132, 2007.
DOI : 10.1097/ICO.0b013e31802eb264

C. Sotozono, M. Ueta, N. Koizumi, T. Inatomi, Y. Shirakata et al., Diagnosis and Treatment of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis with Ocular Complications, Ophthalmology, vol.116, issue.4, pp.685-90, 2009.
DOI : 10.1016/j.ophtha.2008.12.048

F. Lebargy, P. Wolkenstein, M. Gisselbrecht, F. Lange, J. Fleury-feith et al., Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study, Intensive Care Medicine, vol.123, issue.12, pp.1237-1281, 1997.
DOI : 10.1007/s001340050492

J. Revuz, D. Penso, J. Roujeau, J. Guillaume, C. Payne et al., Toxic epidermal necrolysis. Clinical findings and prognosis factors in 87 patients, Archives of Dermatology, vol.123, issue.9, pp.1160-1165, 1987.
DOI : 10.1001/archderm.123.9.1160

!. &n-!-53, S. Klein, and M. Khan, Hepatitis, toxic epidermal necrolysis and pancreatitis in association with sulindac therapy, J Rheumatol, vol.10, pp.512-515, 1983.

T. Palmieri, D. Greenhalgh, J. Saffle, R. Spence, M. Peck et al., A Multicenter Review of Toxic Epidermal Necrolysis Treated in U.S. Burn Centers at the End of the Twentieth Century, Journal of Burn Care & Rehabilitation, vol.23, issue.2, pp.87-96, 2002.
DOI : 10.1097/00004630-200203000-00004

A. Oplatek, K. Brown, S. Sen, M. Halerz, K. Supple et al., Long-Term Follow-Up of Patients Treated for Toxic Epidermal Necrolysis, Journal of Burn Care & Research, vol.27, issue.1, pp.26-33, 2006.
DOI : 10.1097/01.bcr.0000194268.01514.f8

T. Mcgee and A. Munster, Toxic Epidermal Necrolysis Syndrome: Mortality Rate Reduced with Early Referral to Regional Burn Center, Plastic and Reconstructive Surgery, vol.102, issue.4, pp.1018-1040, 1998.
DOI : 10.1097/00006534-199809020-00014

O. Faye and J. Roujeau, Treatment of Epidermal Necrolysis with High-Dose Intravenous Immunoglobulins (IVIg), Drugs, vol.25, issue.15, pp.2085-90, 2005.
DOI : 10.2165/00003495-200565150-00002

Y. Mukasa and N. Craven, Management of toxic epidermal necrolysis and related syndromes, Postgraduate Medical Journal, vol.84, issue.988, pp.60-65, 2008.
DOI : 10.1136/pgmj.2007.061465

S. Magina, C. Lisboa, V. Leal, J. Palmares, and J. Mesquita-guimarães, Dermatological and Ophthalmological Sequels in Toxic Epidermal Necrolysis, Dermatology, vol.207, issue.1, pp.33-39, 2003.
DOI : 10.1159/000070938

R. Sheridan, J. Schulz, C. Ryan, J. Schnitzer, D. Lawlor et al., Long-Term Consequences of Toxic Epidermal Necrolysis in Children, PEDIATRICS, vol.109, issue.1, pp.74-82, 2002.
DOI : 10.1542/peds.109.1.74

L. Yip, B. Thong, J. Lim, A. Tan, H. Wong et al., Ocular manifestations and complications of Stevens?Johnson syndrome and toxic epidermal necrolysis: an Asian series, Allergy, vol.95, issue.5, pp.527-558, 2007.
DOI : 10.1038/sj.eye.6701653

H. Autorité and D. Santé, Available from: http://www.hassante .fr/portail/upload/docs/application/pdf/2011-01/ald_31_pnds_sjs_lyell_web.pdf 64, 2010.

A. Khoo and C. Foo, Toxic epidermal necrolysis in a burns centre: A 6-year review, Burns, vol.22, issue.4
DOI : 10.1016/0305-4179(95)00140-9

A. Fellahi, K. Zouhair, A. Amraoui, and H. Benchikhi, S??quelles cutan??omuqueuses et oculaires des SJS et de Lyell, Annales de Dermatologie et de V??n??r??ologie, vol.138, issue.2, pp.88-92, 2011.
DOI : 10.1016/j.annder.2010.10.029

J. Haber, W. Hopman, M. Gomez, and R. Cartotto, Late Outcomes in Adult Survivors of Toxic Epidermal Necrolysis After Treatment in a Burn Center, Journal of Burn Care & Rehabilitation, vol.26, issue.1, pp.33-41, 2005.
DOI : 10.1097/01.BCR.0000150215.78220.79

B. Rzany, M. Mockenhaupt, S. Baur, W. Schröder, U. Stocker et al., Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990???1992): Structure and results of a population-based registry, Journal of Clinical Epidemiology, vol.49, issue.7, pp.769-73, 1996.
DOI : 10.1016/0895-4356(96)00035-2

J. Roujeau, J. Guillaume, J. Fabre, D. Penso, M. Fléchet et al., Toxic Epidermal Necrolysis (Lyell Syndrome), Archives of Dermatology, vol.126, issue.1, pp.37-42, 1981.
DOI : 10.1001/archderm.1990.01670250043005

A. Roux, Syndrome de LyellT: à propos de 17 cas étudiés de 1980 à 1985 dans le service des brûlés de Bordeaux, 1987.

D. Jesus, L. Dekermacher, S. Manhães, C. Faria, L. Barros et al., Acquired Labial Sinechiae and Hydrocolpos Secondary to Stevens-Johnson Syndrome, Urology, vol.80, issue.4, pp.919-940, 2012.
DOI : 10.1016/j.urology.2012.06.051

R. Hart, C. Minto, and C. S. , Vaginal Adhesions Caused by Stevens-Johnson Syndrome, Journal of Pediatric and Adolescent Gynecology, vol.15, issue.3, pp.151-153, 2002.
DOI : 10.1016/S1083-3188(02)00146-8

I. Niemeijer, M. Van-praag, and N. Van-gemund, Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology, Archives of Gynecology and Obstetrics, vol.105, issue.2, pp.851-855, 2009.
DOI : 10.1007/s00404-009-1008-1

E. Wilson and L. Malinak, Vulvovaginal sequelae of Stevens-Johnson syndrome and their management, Obstet Gynecol, vol.71, pp.478-80, 1988.

E. Meneux, P. Wolkenstein, B. Haddad, J. Roujeau, J. Revuz et al., Vulvovaginal Involvement in Toxic Epidermal Necrolysis: A Retrospective Study of 40 Cases, Obstetrics & Gynecology, vol.91, issue.2, pp.283-290, 1998.
DOI : 10.1016/S0029-7844(97)00596-6

M. Ellis, C. Oster, G. Turiansky, and J. Blanchard, A case report and a proposed algorithm for the transfer of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis to a burn center, Mil Med, vol.167, pp.701-705, 2002.

K. Kim, D. Lee, H. Suh, M. Lee, J. Choi et al., Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients, Acta Derm Venereol, vol.85, pp.497-502, 2005.

!. &=-!-80 and R. Ruiz-maldonado, Acute disseminated epidermal necrosis types 1, 2, and 3: study of sixty cases, J Am Acad Dermatol, vol.13, pp.623-658, 1985.

J. Wilkins, L. Morrison, and C. White, Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum, Dermatol Clin, vol.10, pp.571-82, 1992.

D. Pascuale, M. Espana, E. Liu, D. Kawakita, T. Li et al., Correlation of Corneal Complications with Eyelid Cicatricial Pathologies in Patients with Stevens???Johnson Syndrome and Toxic Epidermal Necrolysis Syndrome, Ophthalmology, vol.112, issue.5, pp.904-916, 2005.
DOI : 10.1016/j.ophtha.2004.11.035

A. Sanmarkan, T. Sori, D. Thappa, and T. Jaisankar, Retrospective analysis of stevensjohnson syndrome and toxic epidermal necrolysis over a period of 10 years, Indian J Dermatol, vol.56, pp.25-34, 2011.

J. Gueudry, J. Roujeau, M. Binaghi, G. Soubrane, and M. Muraine, Risk Factors for the Development of Ocular Complications of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis, Archives of Dermatology, vol.145, issue.2, pp.157-62, 2009.
DOI : 10.1001/archdermatol.2009.540

R. Hazin, O. Ibrahimi, M. Hazin, and A. Kimyai-asadi, Stevens???Johnson syndrome: Pathogenesis, diagnosis, and management, Annals of Medicine, vol.138, issue.2, pp.129-167, 2008.
DOI : 10.1038/sj.jid.5700068

A. Downey, C. Jackson, N. Harun, and A. Cooper, Toxic epidermal necrolysis: Review of pathogenesis and management, Journal of the American Academy of Dermatology, vol.66, issue.6, pp.995-1003, 2012.
DOI : 10.1016/j.jaad.2011.09.029

T. Patel, M. Barvaliya, D. Sharma, and C. Tripathi, A systematic review of the druginduced Stevens-Johnson syndrome and toxic epidermal necrolysis in Indian population

N. Kamada, K. Kinoshita, Y. Togawa, T. Kobayashi, H. Matsubara et al., Chronic pulmonary complications associated with toxic epidermal necrolysis: Report of a severe case with anti-Ro/SS-A and a review of the published work, The Journal of Dermatology, vol.148, issue.9, pp.616-638, 2006.
DOI : 10.1111/j.1600-0560.1995.tb01420.x

P. Sedghizadeh, S. Kumar, A. Gorur, C. Mastin, and A. Boros, Toxic epidermal necrolysis with a rare long-term oral complication requiring surgical intervention, Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology, vol.105, issue.4, pp.29-33, 2008.
DOI : 10.1016/j.tripleo.2007.12.023